Chiron Real Estate (XRN) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

-$0.65

Estimate

-$0.70

Surprise

+7.2%

Score at report (before → after)

5.9 → 5.9/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Chiron Real Estate (XRN) reported a narrower loss than forecast — adjusted EPS of -$0.65 against the -$0.70 estimate (a 7.2% beat on a still-unprofitable quarter). TrendMatrix's engine moved from Buy (Wait) (5.9/10) to Sell at 5.9/10 after the report.

TrendMatrix currently rates XRN Buy (Wait) at 5.9/10.

1 of the last 4 quarters beat the estimate; this quarter's +7.2% surprise compares with a -368.3% four-quarter average. Next scheduled report: 2027-02-24.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$29.49

Entry target

$28.66

Price target

$37.52

Stop

$27.25

Upside to target

+27.2%

Reward-to-risk

3.5:1

Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.

REIT quarters hinge on occupancy, rate exposure, and FFO rather than headline EPS, which mechanically distorts under depreciation.

Industry

REIT - Healthcare Facilities

Market cap

$430.2M

P/E (fwd)

-9.3

P/E (ttm)

8.5

52-week range

$28.09–$38.65

Off 52-week high

23.7%

RSI (14)

50

Volume vs avg

0.15×

Score today

5.9/10